Bill Risks Confusion To Curb FDA's Already-Lax App Oversight

By Jeff Overley (October 29, 2013, 7:33 PM EDT) -- A bipartisan bid to restrict federal oversight of mobile medical apps could create confusion as it tries to solve a problem many observers say doesn't really exist, given the U.S. Food and Drug Administration's hands-off approach to the software so far.

The bill unveiled last week, sponsored by three Republicans and three Democrats, would allow FDA to continue policing apps that function as medical devices but would bar the agency from supervising less-risky software.

Attorneys concede that lawmakers have a worthy goal of encouraging innovation and capital investment by eliminating question marks about the scope of government power in the fast-growing...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!